SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: VLAD who wrote (18503)2/2/1999 5:50:00 PM
From: Mkilloran  Read Replies (1) of 23519
 
Vlad...I agree it is Vivus that had to file with the EU ..they did and it was approved Dec 1st 1998. The next step normally takes 30 day or so for each country to license a drug approved by the EU.

For whatever reason Leland Wilson was being very conservative regarding dates.

Maybe since everyone was getting a little crazy over the DEC 31st date to sign a partner to start asap after ALZA contract expired.

If the countries in Europe license earlier you still have to wait on Astra to Launch the marketing program in each country.

We'll see how it comes together in the next few months.

Some of the unknowns at this time may be related to the Astra/Zeneca
merger. Some may be related to the UK's NHS 6 week study that was started Jan 22nd.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News